Rigel Pharmaceuticals
RIGL
#7539
Rank
C$0.43 B
Marketcap
$24.54
Share price
-0.70%
Change (1 day)
46.60%
Change (1 year)

Earnings for Rigel Pharmaceuticals (RIGL)

Earnings in 2024 (TTM): C$15.8 Million

According to Rigel Pharmaceuticals's latest financial reports the company's current earnings are C$0.15 Billion. In 2023 the company made an earning of -C$26.16 Million, an increase over its 2022 earnings that were of -C$78.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Rigel Pharmaceuticals from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) C$15.8 M-160.43%
2023 -C$26.16 Million-66.79%
2022 -C$78.78 Million340.73%
2021 -C$17.88 Million-56.15%
2020 -C$40.77 Million-57.34%
2019 -C$95.57 Million-7.66%
2018 -C$0.11 Billion-9.47%
2017 -C$0.12 Billion24.46%
2016 -C$91.85 Million23.63%
2015 -C$74.3 Million-43.29%
2014 -C$0.14 Billion2.5%
2013 -C$0.13 Billion
2010 C$54.35 M-133.97%
2009 -C$0.17 Billion-18.49%
2008 -C$0.2 Billion71.91%
2007 -C$0.12 Billion84.74%
2006 -C$61.81 Million-10.17%
2005 -C$68.81 Million-15.73%
2004 -C$81.65 Million39.29%
2003 -C$58.62 Million10.3%
2002 -C$53.15 Million48.3%
2001 -C$35.84 Million-2.13%
2000 -C$36.63 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.19 Billion-1,211.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.2 Billion-1,242.21%๐Ÿ‡บ๐Ÿ‡ธ USA
C$13.84 B 81,961.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$6.71 B 39,717.89%๐Ÿ‡บ๐Ÿ‡ธ USA